Skip to content

Drug interactions

Everolimus + Lumacaftor / ivacaftor

Severity: Major

Everolimus and Lumacaftor / ivacaftor: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lumacaftor is a strong CYP3A inducer and can substantially reduce everolimus exposure. This may cause therapeutic failure, including transplant rejection or loss of antitumor activity.

What this interaction means in plain words

Everolimus and Lumacaftor / ivacaftor can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Lumacaftor induces CYP3A4 (and possibly P-gp), accelerating everolimus clearance.

What to do

Avoid the combination where possible. If it is unavoidable, monitor everolimus trough levels and increase the dose as needed, then reassess when lumacaftor is stopped.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Everolimus and Lumacaftor / ivacaftor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Everolimus with Lumacaftor / ivacaftor?

MediHelp rates the interaction as major. Everolimus and Lumacaftor / ivacaftor can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Lumacaftor is a strong CYP3A inducer and can substantially reduce everolimus exposure. This may cause therapeutic failure, including transplant rejection or loss of antitumor activity.

How serious is the interaction between Everolimus and Lumacaftor / ivacaftor?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible. If it is unavoidable, monitor everolimus trough levels and increase the dose as needed, then reassess when lumacaftor is stopped.

What other medicines interact with Everolimus?

MediHelp also lists interactions of Everolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Levoketoconazole. The full list is on the Everolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in